Research

Get Involved in Diabetes Research

advertisement

Looking to make a difference in the world of type 1 diabetes? Consider signing up for a clinical trial! Getting involved in studies helps improve diabetes care for all. Some studies are simply online surveys, where others are testing out new diabetes devices or medications.

Listed below are studies that are currently recruiting participants, with links where you can contact the study coordinator or center. You can also check out clinicaltrials.gov and search for “type 1 diabetes” to find all active clinical trials in the U.S. 

Current Studies

    • NEW: The University of Minnesota is conducting a study for adults with diabetes and their support person or follower using a behavioral and digital health intervention to see if it helps reduce diabetes distress and improve glycemia. More information.
    • NEW: Medtronic is looking for study participants aged 2-6 years with type 1 diabetes to evaluate the safety of the MiniMed 780G insulin pump with the DS5 CGM. There are multiple locations for the study, and you can find more information here.
    • NEW: We would like to offer you an opportunity to participate in the Post-market Data Collection Program for the MiniMed™ 780G system that will help us continually improve the product of future innovations. To participate in this program, we will ask for the following:
      1. Complete survey data:
        • Complete an initial survey about your system and check your eligibility to participate. After this first survey, we will ask you to complete a short survey twice a month for one year to collect information on your MiniMed™ 780G system experience.
        • You will be compensated for your time spent in completing each survey and for completing a year of participation in the program.
      2. Share device data:
        Provide permission to share your CareLink™ data to gather information about your system’s performance.
        If you are interested in participating or would like to learn more, please use this link. Have your Customer Account Number readily available if you decide to participate.
    • The ISPAD-JENIOUS group has a project developed in collaboration with #dedoc° and INNODIA that aims to investigate the perspectives of parents or caregivers of children and youth with T1D regarding the use of new disease-modifying drugs. They are seeking parents or caregivers of children and adolescents with type 1 diabetes to complete a short survey by using this link. More information and the survey translated into other languages are available here. 
    • 'Time in Tight Range' Survey. Stanford is seeking adult participants living with type 1 diabetes to complete an anonymous survey about your views on a new metric for assessing diabetes outcomes. For more information and to participate, click this link. Participation should take around 15 minutes. For more information, contact the study investigator Molly Tanenbaum, PhD -  [email protected].
    • If you are a woman/birthing person with diabetes, you're invited to participate in an online research study to help learn more about your emotional and health behavior needs and diabetes-related self-management strategies. The study is for anyone who is currently pregnant, planning pregnancy or recently had a baby. For more information and to check eligibility.
    • PREME T1D project – Parents’ peRspectives on disEase-Modifying thErapy in t1D – complete a survey developed in collaboration with #dedoc° and INNODIA, directed to parents/caregivers of children and youth living with T1D aiming to understand their perspectives regarding the use of new disease-modifying drugs.
    • ISPAD JENIOUS special interest group members would like to determine the perceptions of healthcare professionals' regarding the health care team's role in screening psychological concerns and barriers and facilitators to implementing psychosocial screening in practice. Learn more.
    • Researchers at the University of the Sunshine Coast and elsewhere, worldwide, would like to determine the perceptions of healthcare professionals’ regarding the health care team’s role in screening psychological concerns; and [b] barriers and facilitators to implementing psychosocial screening in practice. If you are a healthcare professional currently providing care to patients with diabetes aged <18 years (in any country worldwide), we invite you to participate in an online survey, which will take around 15 minutes to complete. Learn more.
    • If you (or someone you know) have been diagnosed with type 1 diabetes within the last 6 months and are between the ages of 12 to 29, please consider taking part in the DIAGNODE-3 diabetes trial. This study is testing a precision medicine treatment to see if it is able to preserve the body's own insulin-producing capacity by halting or delaying the autoimmune attack on the beta cells. Read more about it and find your nearest clinic at www.diagnode-3.com
    • T1D Transition of Care Program & Research Study at UCSF is looking for young adults aged 18-30 with T1D looking for community and support around growing up with diabetes. Participate in virtual peer groups and complete surveys. Email [email protected] for questions.
    • The Diabetes Wellness Teen Study at Stanford University is investigating risk factors that predict future onset of eating disorders in adolescents with type 1 diabetes. If you are between the ages of 11-17, have type 1 diabetes, and use a continuous glucose monitor, you may be eligible to participate. You could earn up to $125. All activities are completely virtual! Fill out the interest form here and click here to learn more!
    • Are you a young adult who attends/attended college and/or university between the ages of 18-25 with T1D? If you answer yes to all 3 of these questions, then we want to recruit you to learn more about your perceptions as a young adult who is managing type 1 diabetes on a college/university campus. View the pdf to learn more.
    • TrialNet researchers are testing two different treatments – abrocitinib and ritlecitinib – to see if either or both can preserve insulin production in people (ages 12-35) newly diagnosed with type 1 diabetes (Stage 3 T1D). To learn more and sign up for the JAK Inhibitors Newly Diagnosed Study, visit: trialnet.org/jakpot.
    • The Designate Study aims to see how the experimental study drug, siplizumab, can block or weaken the cells that attack beta cells in the pancreas. This would allow the beta cells to continue to function and produce insulin. The study is for those 18 - 45 years of age, diagnosed with T1D in the last 18 months. Compensation is provided. If interested contact Hali at 303-724-7526 or check out: www.designate-study.org.
    • Indiana University is studying a drug known as difluoromethylornithine (DFMO) that may reduce stress in cells that make insulin and preserve your body’s own insulin production. To learn more and to see if you qualify, click here.
    • Are you an adult 60 years or older with Type 1 Diabetes who uses a CGM? University of Utah College of Nursing is conducting a study for adults and their partners who are able to view CGM data on their phone. If you're interested please contact Bruno Gonzalez [email protected]
    • If you have a child aged 2 - 5 years with Type 1 diabetes who is not on an insulin pump, they may be eligible for a new study. This study will explore how Artificial Intelligence (AI) can help doctors choose pump settings in a system that uses automated insulin delivery. The study is sponsored by NIH. For more information go to: www.jaeb.org/pedapai
  • The T1D RELAY This study is testing rituximab-pvvr and abatacept in people (ages 8-45) who were newly diagnosed with type 1 diabetes (T1D) to learn if using both immune therapies, one after the other, maintains the body’s ability to make insulin. By adding abatacept after rituximab-pvvr, researchers predict more people will experience prolonged beta cell function during and possibly after treatment. Learn more and enroll here.
  • An international research team would like to determine the perceptions of adolescents, young adults, their adult carers, and healthcare professionals around the transition from paediatric to adult diabetes healthcare services. We intend to use study findings to help formulate international consensus guidelines on transition between paediatric and adult-based diabetes healthcare services (by the International Society for Pediatric and Adolescent Diabetes, the American Diabetes Association, and the European Association for the Study of Diabetes). As a person with diabetes (or adult carer), we invite you to participate in an online survey, which will take around 15 minutes to complete. Learn more.
  • TrialNet researchers are testing low-dose anti-thymocyte globulin (ATG), an immunotherapy, to find out if it can delay or prevent type 1 diabetes (T1D) in people at high risk of clinical diagnosis (Stage 3) within two years. Learn more.
  • Researchers at Texas Children's Hospital are looking for Teenagers with diabetes aged 14-17 to make videos that empower younger children living with type 1 diabetes. They encourage you to get creative and have fun with this project! The sign-up link is here.
  • The National Institute of Diabetes and Digestive Kidney Diseases is sponsoring a pilot study in people with T1DM who are over 60 years old and use a CGM device. Learn more here.
  • Coin 2 dose is a study for Teenagers with diabetes between the ages of 11-17 years old who have had T1D for at least 6 months. The study is looking to help improve bolusing in teenagers. For more information, there is a video at this link.
  • Stanford University is looking for people with diabetes who have been hospitalized or gone to an emergency department in the last year. They have a survey about experiences with diabetes technology in the hospital setting.
  • Study for adults with T1D ages 18-45 seeing if a new medically designed probiotic will improve beta cell function, gastrointestinal health, immune function, and c-peptide levels in study participants. The study is at the University of Florida Campus in Gainesville, Florida and involves 4 in-person visits over a year. Must be willing to consume study probiotic capsule daily for 24 weeks. Contact Miriam Cintron, study coordinator, [email protected] for more information.
  • Researchers at the University of Texas are looking for Young Adults between the ages of 18-25 with Diabetes or other qualifying health conditions to participate in a research study investigating what influences readiness to transition to adult care. This will be a one-time online survey. For more information please contact at this email: [email protected] or this phone number: 512-593-2360.
  • Survey for parents of children with chronic health conditions at Baylor University. Parent and siblings participate in zoom sessions and complete questionnaires. For more information and interest to participate, please contact: Tatum Zeleznik at [email protected] 
  • A 2nd year PhD student at Rosalind Franklin University of Medicine and Science is conducting a study that seeks to understand more about the relationships young adults (age 18-29) with type 1 diabetes have with their medical providers, and how these relationships impact their diabetes management. If you are between the ages of 18-29, have type 1 diabetes, have seen your endocrinologist in the last year, and can read English please consider participating! Learn more about the study and take the survey.
  • Are you the parent of an emerging adult (aged 15-25) with type 1 diabetes? The purpose of this study is to identify desired types and mechanisms of support for parents during their emerging adult’s transition to adulthood with T1D. Click here to access the confidential online screening questionnaire. Participants who complete both the survey and the focus group will be entered into a drawing to win a $100 Amazon.com e-gift card!
  • The purpose of the VX-880 Islet Cell Infusion study sponsored by Vertex Pharmaceuticals is to evaluate the safety, tolerability, and effectiveness of an investigational islet cell infusion called VX-880. The goal of this infusion is to provide replacement cells for the ones that have been lost or don’t work properly in people with diabetes. Participants may be compensated financially for study-related time and reimbursed for travel. Learn more and see if you qualify.
  • The MAS-1 Study is working to prove that MAS-1 vaccine is safe and promotes anti-inflammatory pathways while decreasing auto-inflammatory actions in the body. This study is looking for patients diagnosed with T1D within previous 2 years who are 18-45 years old. Learn more. For questions, contact Hali Broncucia at [email protected].
  • Little is known about how families manage diabetes when multiple family members have type 1 diabetes. Such families may have strategies they share that make living with T1D easier. The University of Utah is conducting a multi T1 study - get more information here!

Do you have a research study that we can promote? Use our Contact Us form to let us know.

advertisement